Publications by authors named "Phillip Grovenstein"

Claim this Profile
A
A combination of new prefusion mRNA and protein vaccines enhances neutralizing antibodies and protection against respiratory syncytial virus.
Surya Sekhar Pal, Ki-Hye Kim, Noopur Bhatnagar, Phillip Grovenstein, Jannatul Ruhan Raha

Vaccine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
Jannatul Ruhan Raha, Ki-Hye Kim, Chau Thuy Tien Le, Noopur Bhatnagar, Rong Liu, Phillip Grovenstein

Virology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination.
Chau Thuy Tien Le, Ki-Hye Kim, Jannatul Ruhan Raha, Noopur Bhatnagar, Surya Sekhar Pal, Phillip Grovenstein

J Virol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranasal vaccination with multi-neuraminidase and M2e virus-like particle vaccine results in greater mucosal immunity and protection against influenza than intramuscular injection.
Jannatul Ruhan Raha, Ki-Hye Kim, Chau Thuy Tien Le, Noopur Bhatnagar, Surya Sekhar Pal, Phillip Grovenstein

Vaccine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
Phillip Grovenstein, Noopur Bhatnagar, Ki-Hye Kim, Surya Sekhar Pal, Chau Thuy Tien Le

J Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
Ki-Hye Kim, Noopur Bhatnagar, Jeeva Subbiah, Rong Liu, Surya Sekhar Pal, Phillip Grovenstein

Virology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice.
Jannatul Ruhan Raha, Ki-Hye Kim, Noopur Bhatnagar, Rong Liu, Chau Thuy Tien Le, Phillip Grovenstein

Antiviral Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination.
Noopur Bhatnagar, Ki-Hye Kim, Jeeva Subbiah, Sakinah Muhammad-Worsham, Bo Ryoung Park, Phillip Grovenstein

Vaccines (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and molecular characterization of the second Chlamydomonas gun4 mutant, gun4-II.
Phillip B Grovenstein, Darryel A Wilson, Kathryn D Lankford, Kelsey A Gaston, Surangi Perera

F1000Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and molecular characterization of a novel Chlamydomonas reinhardtii mutant defective in chlorophyll biosynthesis.
Phillip B Grovenstein, Darryel A Wilson, Cameron G Lennox, Katherine P Smith, Alisha A Contractor

F1000Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis